Antiepileptics in the treatment of alcohol withdrawal and alcohol use relapse prevention

Mark A. Frye; Victor M. Karpyak; Daniel Hall-Flavin; Ihsan M. Salloum; Andrew McKeon; Doo Sup Choi

doi:10.3109/9780849382666-16

Antiepileptics in the treatment of alcohol withdrawal and alcohol use relapse prevention

Mark A. Frye, Victor M. Karpyak, Daniel Hall-Flavin, Ihsan M. Salloum, Andrew McKeon, Doo Sup Choi

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

In the World Health Organization’s Global Burden of Disease Study (1), alcohol use disorders (abuse and dependence) ranked fifth in the undeveloped world and second in the developed world (ages 15-44 years) in disability-adjusted life years (DALYs); this measure is a composite of time lost because of premature mortality and time lived with a disability. In the United States alone, approximately 18 million people, or 7% of the population, suffer from alcohol abuse or dependence. The direct and indirect economic burden ascribed to alcohol use is estimated to be $185 billion (2). Clearly, more effective prevention and treatment of this major public health problem is needed.

Original language	English (US)
Title of host publication	Antiepileptic Drugs to Treat Psychiatric Disorders
Publisher	Taylor and Francis
Pages	251-262
Number of pages	12
ISBN (Electronic)	9780849382666
ISBN (Print)	0849382599, 9780849382598
DOIs	https://doi.org/10.3109/9780849382666-16
State	Published - Jan 1 2008

ASJC Scopus subject areas

General Medicine
Pharmacology, Toxicology and Pharmaceutics(all)
General Psychology

Access to Document

10.3109/9780849382666-16

Cite this

@inbook{eac2f532556a426393694f8495c3d714,

title = "Antiepileptics in the treatment of alcohol withdrawal and alcohol use relapse prevention",

abstract = "In the World Health Organization{\textquoteright}s Global Burden of Disease Study (1), alcohol use disorders (abuse and dependence) ranked fifth in the undeveloped world and second in the developed world (ages 15-44 years) in disability-adjusted life years (DALYs); this measure is a composite of time lost because of premature mortality and time lived with a disability. In the United States alone, approximately 18 million people, or 7% of the population, suffer from alcohol abuse or dependence. The direct and indirect economic burden ascribed to alcohol use is estimated to be $185 billion (2). Clearly, more effective prevention and treatment of this major public health problem is needed.",

author = "Frye, {Mark A.} and Karpyak, {Victor M.} and Daniel Hall-Flavin and Salloum, {Ihsan M.} and Andrew McKeon and Choi, {Doo Sup}",

year = "2008",

month = jan,

day = "1",

doi = "10.3109/9780849382666-16",

language = "English (US)",

isbn = "0849382599",

pages = "251--262",

booktitle = "Antiepileptic Drugs to Treat Psychiatric Disorders",

publisher = "Taylor and Francis",

}

TY - CHAP

T1 - Antiepileptics in the treatment of alcohol withdrawal and alcohol use relapse prevention

AU - Frye, Mark A.

AU - Karpyak, Victor M.

AU - Hall-Flavin, Daniel

AU - Salloum, Ihsan M.

AU - McKeon, Andrew

AU - Choi, Doo Sup

PY - 2008/1/1

Y1 - 2008/1/1

N2 - In the World Health Organization’s Global Burden of Disease Study (1), alcohol use disorders (abuse and dependence) ranked fifth in the undeveloped world and second in the developed world (ages 15-44 years) in disability-adjusted life years (DALYs); this measure is a composite of time lost because of premature mortality and time lived with a disability. In the United States alone, approximately 18 million people, or 7% of the population, suffer from alcohol abuse or dependence. The direct and indirect economic burden ascribed to alcohol use is estimated to be $185 billion (2). Clearly, more effective prevention and treatment of this major public health problem is needed.

AB - In the World Health Organization’s Global Burden of Disease Study (1), alcohol use disorders (abuse and dependence) ranked fifth in the undeveloped world and second in the developed world (ages 15-44 years) in disability-adjusted life years (DALYs); this measure is a composite of time lost because of premature mortality and time lived with a disability. In the United States alone, approximately 18 million people, or 7% of the population, suffer from alcohol abuse or dependence. The direct and indirect economic burden ascribed to alcohol use is estimated to be $185 billion (2). Clearly, more effective prevention and treatment of this major public health problem is needed.

UR - http://www.scopus.com/inward/record.url?scp=85076659603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076659603&partnerID=8YFLogxK

U2 - 10.3109/9780849382666-16

DO - 10.3109/9780849382666-16

M3 - Chapter

SN - 0849382599

SN - 9780849382598

SP - 251

EP - 262

BT - Antiepileptic Drugs to Treat Psychiatric Disorders

PB - Taylor and Francis

ER -

Antiepileptics in the treatment of alcohol withdrawal and alcohol use relapse prevention

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this